Grants for Researchers

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Lung Cancer Translational Research Award funds advanced translational lung cancer research, including late-stage preclinical work or pilot clinical trials, addressing the program's FY26 areas of emphasis. Eligibility is stated as unrestricted (open to any eligible entity type), so review the program announcement for specific organization categories. Award amounts are not specified here. This is a research-focused defense health opportunity.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Prostate Cancer Early Investigator Research Award funds prostate cancer research conducted by early-career investigators with fewer than three years of postdoctoral experience, guided by an experienced mentor. Applications must include at least one experienced prostate cancer research mentor and a researcher development plan. Eligibility is otherwise stated as unrestricted, so review the program announcement for specific organization categories. Award amounts are not specified here.

Department of Pesticide Regulation · $100K–$1M

California's Department of Pesticide Regulation (DPR) 2027 Sustainable Pest Management Grants Program is open to a broad range of applicants, including nonprofits, businesses, individuals, universities, and government and tribal agencies. It funds projects that advance integrated pest management practices, such as alternatives to weed, rodent, and fumigant use, through research, outreach, and implementation in agricultural, urban, or wildland settings, with award budgets ranging from $100,000 to $1,000,000. Principal investigators may submit at most two proposals per year, and all applicants must meet DPR's specific eligibility requirements outlined in the official solicitation. Applications are due by September 2, 2026.

National Institutes of Health · Amount varies

This NIH R01 funds research into the cellular, molecular, and circuit-level biology underlying complex brain disorders, supporting hypothesis-generating or hypothesis-testing studies using model organisms or human cell-based assays. It's intended for researchers with feasibility or proof-of-concept already established (early-stage exploratory work should apply to a companion R21 instead). Eligible U.S. institutions include HBCUs and tribal colleges; the deadline is September 7, 2026.

National Institutes of Health · Amount varies

This NIH P41 opportunity funds Biomedical Technology Resource Centers that develop new research technologies, train other researchers in their use, and share them broadly with the scientific community. It's aimed at eligible U.S. research institutions (HBCUs and tribal colleges included); foreign organizations are not eligible. The deadline is September 7, 2026.

National Institutes of Health · Amount varies

This NIH (NIAAA) R34 award supports planning and pilot health services research aimed at closing the treatment gap for alcohol use disorder. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here, though R34 grants are typically smaller, planning-stage awards. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH R01 award funds translational research on schizophrenia and related disorders in mid- to late-life, aiming to clarify illness trajectory and identify prevention and treatment targets. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Up to $500K

This NIH (NIAAA) R01 award funds health services research aimed at closing the treatment gap for alcohol use disorder, including improving access to and appeal of treatment and reducing disparities. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. The stated maximum award is about $500,000. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH (NIAAA) R34 award supports planning and pilot research on alcohol use disorder treatment and recovery; a clinical trial is required. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here, though R34 grants are typically smaller, planning-stage awards. Applications are submitted through eligible organizations.

National Institutes of Health · Amount varies

This NIH R01 award funds research into the mechanisms behind neuropsychiatric symptoms in Alzheimer's disease and related dementias, with the goal of identifying novel therapeutic targets. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH R21 award funds exploratory research into the mechanisms behind neuropsychiatric symptoms in Alzheimer's disease and related dementias, with the aim of revealing novel therapeutic targets. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH R36 award funds up to two years of doctoral dissertation research on substance use and substance use disorders, aligned with NIDA funding priorities, aimed at doctoral candidates across academic disciplines. Eligible U.S. institutions include HBCUs, tribal colleges, and minority-serving institutions; foreign organizations are not eligible. The deadline is September 7, 2026.

National Institutes of Health · Amount varies

This NIH/National Cancer Institute R01 award supports assay development and screening to discover small-molecule chemical probes, drugs, or immunomodulators, with no clinical trials allowed. It is aimed at research institutions and investigators conducting early-stage discovery research, and lists a broad set of eligible U.S. organization types. Funding amounts are not specified here. Applications are submitted through eligible organizations.

National Institutes of Health · Amount varies

This NIH R21 award funds exploratory translational research on schizophrenia and related disorders in mid- to late-life, aiming to understand illness trajectory and identify prevention and treatment targets. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations.

National Institutes of Health · Up to $499K

This NIH/National Cancer Institute R01 award funds projects to improve the reliability and translational usefulness of mammalian cancer and tumor models, with no clinical trials allowed. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. The stated maximum award is about $499,000. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH R21 award supports early-stage, high-risk exploratory research into the cellular, molecular, and circuit biology of risk factors for complex brain disorders, with no clinical trials allowed. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH R01 award funds research on how social isolation and loneliness raise suicide risk in older adults, including mechanism studies and intervention development and testing. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. Award amounts are not specified here. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Up to $500K

This NIH (NIAAA) R01 award funds treatment, pharmacotherapy, and recovery research for alcohol use disorder, including medications development, behavioral therapies, and recovery science; a clinical trial is required. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. The stated maximum award is about $500,000. Applications are submitted through eligible organizations.

National Institutes of Health · Amount varies

This NIH R21 funds research into how social isolation and loneliness affect suicide risk in older adults, including studies on neurobiological and environmental mechanisms, intervention testing, and service-delivery models. It's open to eligible U.S. research institutions (HBCUs and tribal colleges included). The deadline is September 7, 2026.

U.S. National Science Foundation · $2M–$3M

This NSF Research Traineeship (NRT) program funds universities to develop interdisciplinary STEM graduate training models in high-priority research areas. Only U.S. institutions of higher education may apply, and the PI must be a faculty member at the submitting institution, so this is restricted to higher education. Awards range from roughly $2,000,000 to $3,000,000. Individuals, nonprofits, and businesses are not eligible to apply directly.